Preview

Развитие гипогликемических состояний после билиопанкреатического шунтирования по поводу морбидного ожирения: клинический случай

https://doi.org/10.14341/2071-8713-3864

Полный текст:

Аннотация

Изменения углеводного обмена после шунтирующих бариатрических операций связаны c изменением продукции инкретинов – биологически активных веществ, вырабатывающихся в тонком кишечнике в ответ на поступление пищи. Гипогликемические состояния, возникающие после бариатрических вмешательств, зачастую имеют функциональную природу (демпинг-синдром) и могут быть успешно скорректированы путем выполнения диетических рекомендаций. В то же время, описаны многочисленные случаи развития незидиобластоза у пациентов, перенесших гастрошунтирование. В данной статье приводится описание постпрандиальных гипогликемических состояний функционального характера у пациента, перенесшего билиопанкреатическое шунтирование по поводу морбидного ожирения.

Список литературы

1. Akimov V, et al. A new view on pathogenesis of dumping-syndrome. Vestn Khir II Grek. 2008; 167: 22–5.

2. Anlauf M, et al. Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am J Surg Pathol. 2005; 29: 524–33.

3. Baggio L, et al. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007; 132: 2131–57.

4. Bantle J, et al. Hyperinsulinemic hypoglycemia developing late after gastric bypass. Obes Surg. 2007; 17: 592–4.

5. Beckman L, et al. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. J Parenter Enteral Nutr. 2011; 35: 169–180.

6. Bendix F, et al. Weight loss and changes in salivary ghrelin and adiponectin: Comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding. Obes Surg 2011; doi:10-1007/sl1695-011-0374-5.

7. Bernard B, et al. Hypoglycaemia following upper gastrointestinal surgery: case report and review of the literature. BMC Gastroenterology. 2010; 10: 77.

8. Brechner R, et al. A graded evidence-based summary of evidence for bariatric surgery. Surg Obes Relat Dis. 2005; 1: 430–441.

9. Buchwald H, et al. Metabolic bariatric surgery Worldwide 2008. Obes Surg. 2009; 19: 1605–11.

10. Bult M. et al. Surgical treatment of obesity. Eur J Endocrinol. 2008; 158 (2): 135–45.

11. Clancy T et al. Post-gastric bypass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglycemia. J Gastrointest Surg. 2006; 10: 1116–9.

12. Clifton P. Bariatric surgery: results in obesity and effects on metabolic parameters. Current Opinion in Lipidology. 2011; 22: 1–5.

13. Cui Y, et al. Advances in the Etiology and Management of Hyperinsulinemic Hypoglycemia After Roux-en-Y Gastric Bypass. J Gastrointest Surg. 2011; 15: 1879–88.

14. Deitel M. The change in the dumping syndrome concept. Obes Surg. 2008; 18: 1622–4.

15. Dirksen C et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia. 2012; 55: 1890–901.

16. Edholm T, et al. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis. Neurogastroenterology & Motility. 2010; 22, 1191–1200, e315.

17. Goldfine A, et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin responses to a mixed meal. J Clin Endocrinol Metab. 2007; 92: 4678–85.

18. Heber D, et al. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2010; 95(11): 4823–43.

19. Heinlein C. Dumping Syndrome in Roux-en-Y Bariatric Surgery Patients: Are They Prepared? Bariatric nursing and surgical patient care. 2009; 4(1): 39–47.

20. Holst J. The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87:1409–1439

21. Kim S, et al. Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia. Obes Surg. 2009; 19: 1550–1556.

22. Lamounier R, et al. Incretins: clinical physiology and bariatric surgery- correlating the entero-endocrine system and a potentially anti-dysmetabolic procedure. Obes Surg. 2007; 17: 569–76.

23. le Roux C, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006; 243: 108–14.

24. Marsk R, et al. Nationwide cohort study of post-gastric bypass hypoglycemia including 5,040 patients undergoing surgery for obesity in 1986–2006 in Sweden. Diabetologia. 2010; 53: 2307–11.

25. Mason E, Gastric emptying controls type 2 diabetes mellitus (Editorial). Obes Surg. 2007; 17: 853–5.

26. McLaughlin T, et al. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab. 2010; 95: 1851–5.

27. Mechanick J, et al. AACE/TOS/ASMBS Guidelines. Surgery for Obesity and Related Diseases. 2008; 4: S109–84.

28. Neary M, et al. Gut hormones: implications for the treatment of obesity. Pharmacology & Therapeutics. 2009; 124: 44–56.

29. Patti M, et al. Hypoglycaemia following gastric bypass surgery:diabetes remission in the extreme? Diabetologia. 2010; 53: 2276–2279.

30. Patti M, et al. Severe hypoglycaemia postgastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia. 2005; 48: 2236–40.

31. Rabiee A, et al. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: Unraveling the roles of gut hormonal and pancreatic endocrine dysfunction. J Surg Res. 2011; 167: 199–205.

32. Rubino F, et al. The early effect of Roux-en-Y gastric bypass on hormones is involved in body weight regulation and glucose metabolism. Ann Surg. 2004; 240: 236–242.

33. Scavini M, et al. Asymptomatic hyperinsulinemic hypoglycemia after gastric banding. N Engl J Med. 2005; 353: 2822–2823.

34. Service G, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric bypass surgery. N Engl J Med. 2005; 353: 249–54.

35. Thaler J, et al. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009; 150: 2518–25.

36. Ukleja A. Dumping syndrome: pathophysiology and treatment. Nutr Clin Pract. 2005; 20: 517–25.

37. Vella A, et al. Incretin hypersecretion in postgastric bypass hypoglycemia: primary problem or red herring? J Clin Endocrinol Metab. 2007; 92: 4563–5.

38. Vidal J, et al. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab. 2009; 94: 884–91.

39. World Health Organization. Web site [Internet]. Geneva (Switzerland): World Health Organization; 2006. Obesity and overweight. Fact sheet No.311; [cited 2007 Oct 1]. Available from:www.who.int/mediacentre/factsheets/fs311/en/index.html.


Для цитирования:


Mazurina N.V., Ogneva N.A., Yashkov Y.I., Troshina E.A., Melnichenko G.A. Развитие гипогликемических состояний после билиопанкреатического шунтирования по поводу морбидного ожирения: клинический случай. Ожирение и метаболизм. 2013;10(3):44-49. https://doi.org/10.14341/2071-8713-3864

For citation:


., ., ., ., . Hypoglycemia episodes after biliopancreatic diversion for morbid obesity: clinical case presentation. Obesity and metabolism. 2013;10(3):44-49. (In Russ.) https://doi.org/10.14341/2071-8713-3864

Просмотров: 17


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)